Automated Urinary Chemokine Assays for Noninvasive Detection of Kidney Transplant Rejection: A Prospective Cohort Study

22Citations
Citations of this article
24Readers
Mendeley users who have this article in their library.

This article is free to access.

Abstract

Rationale & Objective: Prior studies have demonstrated the diagnostic potential of urinary chemokines C-X-C motif ligand 9 (CXCL9) and CXCL10 for kidney transplant rejection. However, their benefit in addition to clinical information has not been demonstrated. We evaluated the diagnostic performance for detecting acute rejection of urinary CXCL9 and CXCL10 when integrated with clinical information. Study Design: Single-center prospective cohort study. Setting & Participants: We analyzed 1,559 biopsy-paired urinary samples from 622 kidney transplants performed between April 2013 and July 2019 at a single transplant center in Belgium. External validation was performed in 986 biopsy-paired urinary samples. Tests Compared: We quantified urinary CXCL9 (uCXCL9) and CXCL10 (uCXCL10) using an automated immunoassay platform and normalized the values to urinary creatinine. Urinary chemokines were incorporated into a multivariable model with routine clinical markers (estimated glomerular filtration rate, donor-specific antibodies, and polyoma viremia) (integrated model). This model was then compared with the tissue diagnosis according to the Banff classification for acute rejection. Outcome: Acute rejection detected on kidney biopsy using the Banff classification. Results: Chemokines integrated with routine clinical markers had high diagnostic value for detection of acute rejection (n = 150) (receiver operating characteristic area under the curve 81.3% [95% CI, 77.6-85.0]). The integrated model would help avoid 59 protocol biopsies per 100 patients when the risk for rejection is predicted to be below 10%. The performance of the integrated model was similar in the external validation cohort. Limitations: The cross-sectional nature obviates investigating the evolution over time and prediction of future rejection. Conclusions: The use of an integrated model of urinary chemokines and clinical markers for noninvasive monitoring of rejection could enable a reduction in the number of biopsies. Urinary chemokines may be useful noninvasive biomarkers whose use should be further studied in prospective randomized trials to clarify their role in guiding clinical care and the use of biopsies to detect rejection after kidney transplantation. Plain-Language Summary: Urinary chemokines CXCL9 and CXCL10 have been suggested to be good noninvasive biomarkers of kidney transplant rejection. However, defining a context of use and integration with clinical information is necessary before clinical implementation can begin. In this study, we demonstrated that urinary chemokines CXCL9 and CXCL10, together with clinical information, have substantial diagnostic accuracy for the detection of acute kidney transplant rejection. Application of urinary chemokines together with clinical information may guide biopsy practices following kidney transplantation and potentially reduce the need for kidney transplant biopsies.

References Powered by Scopus

Net benefit approaches to the evaluation of prediction models, molecular markers, and diagnostic tests

668Citations
N/AReaders
Get full text

The Banff 2019 Kidney Meeting Report (I): Updates on and clarification of criteria for T cell– and antibody-mediated rejection

566Citations
N/AReaders
Get full text

A 2018 Reference Guide to the Banff Classification of Renal Allograft Pathology

555Citations
N/AReaders
Get full text

Cited by Powered by Scopus

Toward Precision Medicine: Exploring the Landscape of Biomarkers in Acute Kidney Injury

8Citations
N/AReaders
Get full text

Transforming kidney transplant monitoring with urine CXCL9 and CXCL10: practical clinical implementation

2Citations
N/AReaders
Get full text

Evaluation of non-invasive biomarkers of kidney allograft rejection in a prospective multicenter unselected cohort study (EU-TRAIN)

2Citations
N/AReaders
Get full text

Register to see more suggestions

Mendeley helps you to discover research relevant for your work.

Already have an account?

Cite

CITATION STYLE

APA

Van Loon, E., Tinel, C., de Loor, H., Bossuyt, X., Callemeyn, J., Coemans, M., … Naesens, M. (2024). Automated Urinary Chemokine Assays for Noninvasive Detection of Kidney Transplant Rejection: A Prospective Cohort Study. American Journal of Kidney Diseases, 83(4), 467–476. https://doi.org/10.1053/j.ajkd.2023.07.022

Readers' Seniority

Tooltip

PhD / Post grad / Masters / Doc 4

57%

Researcher 3

43%

Readers' Discipline

Tooltip

Medicine and Dentistry 3

38%

Biochemistry, Genetics and Molecular Bi... 2

25%

Nursing and Health Professions 2

25%

Immunology and Microbiology 1

13%

Article Metrics

Tooltip
Mentions
Blog Mentions: 2
News Mentions: 1

Save time finding and organizing research with Mendeley

Sign up for free